Biomarkers and Adjuvant Treatment Planning Strategies for Patients with a Node-Negative, Estrogen Receptor-Positive Breast Cancer
David M. Hyams, MD, FACS and Ruth Oratz, MD, FACP

Molecularly Targeted Therapies for Breast Cancer
Timothy J. Hobday, MD; Edith A. Perez, MD

Monoclonal Antibody Therapy for Breast Cancer
Edith A. Perez, MD - Mayo Clinic Cancer Center, Jacksonville, Florida

Medical Genomics: Implications for Clinical Oncology
Charles H. Weaver, MD, and Dayna Deuter

Prospective Study Confirms that MRI Detects More Breast Cancers in High-risk Women (11/20/2009)
Researchers from the University of Pennsylvania have reported that magnetic resonance imaging (MRI) is superior to digital mammography or ultrasound for the detection of breast cancer in high-risk women. The details of this study appeared in an early online publication in the Journal of Clinical Oncology on November 2, 2009.

New U.S. Preventive Services Task Force Recommendations on Breast Cancer Screening (11/17/2009)
The U.S. Preventive Services Task Force (USPSTF) has released new guidelines for breast cancer screening that increase the interval between screenings for most women. The details of these new guidelines were published in the November 17, 2009 issue of the Annals of Internal Medicine and received prominent first page review in the November 17, 2009 issue of the New York Times.

Lyrica® Decreases Hot Flashes in Women with Breast Cancer (11/17/2009)
Researchers from the Mayo Clinic have reported that Lyrica® (pregabalin, [S]-3-[aminomethyl]-5-methylhexanoic acid) is effective for the treatment of hot flashes in women with breast cancer. The details of this study appeared in an early online publication on November 9, 2009 in the Journal of Clinical Oncology.

Persistent Pain Common After Breast Cancer Surgery (11/16/2009)
Researchers from Denmark have reported that pain and sensory disturbances persist for two to three years after breast cancer surgery. The details of this study were published in the November 11, 2009 issue of the Journal of the American Medical Association.

Excess Body Weight Linked with More Than 100,000 New Cancer Diagnoses Each Year in U.S. (11/12/2009)
According to estimates from the American Institute for Cancer Research (AICR), excess body weight may be responsible for more than 100,000 new cancer diagnoses each year in the United States.